WO1997028687A1 - Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same - Google Patents

Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same Download PDF

Info

Publication number
WO1997028687A1
WO1997028687A1 PCT/US1997/001967 US9701967W WO9728687A1 WO 1997028687 A1 WO1997028687 A1 WO 1997028687A1 US 9701967 W US9701967 W US 9701967W WO 9728687 A1 WO9728687 A1 WO 9728687A1
Authority
WO
WIPO (PCT)
Prior art keywords
dodecylamine
counter ion
composition
alkylene
salt
Prior art date
Application number
PCT/US1997/001967
Other languages
English (en)
French (fr)
Inventor
Fernando Del Corral
Percy Jaquess
David Oppong
Original Assignee
Buckman Laboratories International, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Buckman Laboratories International, Inc. filed Critical Buckman Laboratories International, Inc.
Priority to AU21187/97A priority Critical patent/AU724312B2/en
Priority to NZ331248A priority patent/NZ331248A/xx
Priority to AT97906516T priority patent/ATE209438T1/de
Priority to JP52868297A priority patent/JP3939355B2/ja
Priority to BR9707318A priority patent/BR9707318A/pt
Priority to SK1019-98A priority patent/SK101998A3/sk
Priority to CA002247375A priority patent/CA2247375C/en
Priority to DE69708610T priority patent/DE69708610T2/de
Priority to EP97906516A priority patent/EP0884944B1/en
Publication of WO1997028687A1 publication Critical patent/WO1997028687A1/en
Priority to NO983610A priority patent/NO983610L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02Amines; Quaternary ammonium compounds
    • A01N33/04Nitrogen directly attached to aliphatic or cycloaliphatic carbon atoms

Definitions

  • the present invention relates to certain compositions and processes useful for controlling the growth of one or more microorganisms.
  • the novel processes and mixtures of the present invention show unexpected synergistic activity against microorganisms, including bacteria, fungi and algae.
  • the present invention particularly relates to the use of compositions/mixtures comprising an ionene polymer and a salt of dodecylamine.
  • a large number of commercial industrial and agricultural products are subject to microbiological attacks that reduce or destroy their economic value.
  • products that may be subject to such biological fouling are coatings, wood and wood products, agricultural seed, animal hides, textiles, plastics, adhesives, pharmaceuticals, cosmetics, toiletries, lubricants, agrochemicals, petrochemicals, paints, proteinaceous materials, and the like.
  • the storage temperature of these and other products and the products' intrinsic characteristics make them susceptible to the growth of various microorganisms.
  • These microorganisms can be introduced during manufacturing or handling by exposure to air, tanks, pipes, equipment, humans, or any other agent or environment carrying microbiological contaminants.
  • Aqueous systems such as emulsions, suspensions, or solutions containing organic materials, are also highly subject to microbiological attack.
  • aqueous systems include dyes, latexes, paints, surfactants, dispersants, stabilizers, thickeners, adhesives, starches, waxes, proteins, emulsifying agents, detergents, cellulose products, resins, metalworking fluids, cooling tower fluids, paper mill liquors, tanning liquors, and recreational aqueous systems, i.e., pools, spas, etc., and the like.
  • These systems frequently contain relatively large amounts of water, causing them to be well-suited environments for biological growth and thus attack and degradation.
  • Microbiological fouling and degradation of aqueous systems containing organic materials manifests itself by problems such as loss of viscosity, gas formation, objectionable odors, decreased pH, emulsion breaking, color change, and gelling.
  • Slime can reduce yields from industrial processes using aqueous systems and render recreational aqueous systems unsuitable for use.
  • Slime consists of matted deposits of microorganisms, fibers, and debris. It may be stringy, pasty, rubbery, tapioca-like, or hard, and may have a characteristic undesirable odor that is different from that of the aqueous liquid system in which it is formed.
  • the microbiological contaminants involved in slime formation are primarily different species of spore-forming and nonspore-forming bacteria, particularly capsulated forms of bacteria that secrete gelatinous substances that envelop or encase the cells.
  • Slime microorganisms also include filamentous bacteria, filamentous fungi of the mold type, yeasts, and yeast-like organisms.
  • microbiological organisms responsible for biological fouling of various aqueous systems include various bacteria, fungi, mildews, algaes, and the like.
  • various industrial microbicides are used. Workers in the trade have continued to seek improved biocides that have low toxicity and are capable of exhibiting a prolonged biocidal effect against a wide variety of microorganisms at normal use.
  • Increasingly stringent environmental and safety regulations as well as escalating development costs have created the need for new microbicidal agents selected from known safe and economical materials.
  • lonene polymers i.e., cationic polymers containing quaternary nitrogens in the polymer backbone, is one group of biocides used in controlling bacteria and algae in various aqueous systems. See, e.g., A. Rembaum, "Biological Activity of lonene Polymers," Applied Polymer Symposium No. 22, 299-317 (1973) and O.
  • controlling the growth of at least one microorganism includes both the reduction and/or prevention of such growth. It is to be further understood that by “controlling" the growth of at least one microorganism, the growth of at least one microorganism is inhibited. In other words, there is no growth or substantially no growth of at least one microorganism. "Controlling" the growth of at least one microorganism includes maintaining a microorganism population at a desired level (including undetectable levels such as zero population), reducing a microorganism population to a desired level and/or inhibiting or slowing the growth of at least one microorganism. Thus, materials and media susceptible to attack by at least one microorganism are preserved and/or protected from this attack and the resultant deleterious effects.
  • the present invention provides a composition comprising an ionene polymer and a salt of dodecylamine where the components are present in a combined amount synergistically effective to control the growth of at least one microorganism.
  • the present invention also provides a method for controlling the growth of at least one microorganism in or on a material or medium susceptible to attack by the microorganism which comprises the step of adding to the material or medium a composition of the present invention in an amount synergistically effective to control the growth of the microorganism.
  • the synergistically effec ⁇ tive amount varies in accordance with the material or medium to be treated and can, for a particular application, be routinely determined by one skilled in the art.
  • the present invention also embodies the separate addition of an ionene polymer and a salt of dodecylamine to the products, materials or media described above.
  • the components are individually added to the system so that the final amount present at the time of use is that amount synergistically effective to control the growth of at least one microorganism.
  • compositions of the present invention are also useful in preserving or controlling the growth of microorganisms in various types of industrial media or materials susceptible to attack by microorganisms.
  • media or materials include, but are not limited to, dyes, pastes, lumber, leather, textiles, pulp, wood chips, tanning liquor, a paper mill liquor, a polymer emulsion, a paint, paper and other coating and sizing agents, a metalworking fluid, a geological drilling lubricant, petrochemicals, a cooling water system, recreational water, influent plant water, waste water, pasteurizers, retort cookers, a pharmaceutical formulation, and cosmetic and toiletry formulations.
  • composition can also be useful in agrochemical formulations for the purpose of protecting seeds or crops against microbial spoilage.
  • compositions combining an ionene polymer and a salt of dodecylamine demonstrate an unexpected synergistic effect compared to the respective components alone.
  • these compositions achieve superior, i.e. greater than additive, microbicidal activity, even at low concentrations, against a wide variety of microorganisms.
  • microorganisms include fungi, bacteria and algae such as Trichoderma harzianun. Pseudomonas aeru ⁇ inosa and Chlorella pyrenoidosa.
  • the compositions of the present invention have a low toxicity.
  • ionene polymer or mixture of ionene polymers may be used to practice this invention.
  • lonene polymers may be classified according to the repeating unit found in the polymer. The repeating unit results from the reactants used to make the ionene polymer.
  • a first preferred type of ionene polymer comprises the repeating unit of formula I:
  • R ⁇ R 2 , R 3 , and R 4 can be identical or different, and are selected from H, C ⁇ C alkyl optionally substituted with at least one hydroxyl
  • R 1 , R 2 , R 3 and R 4 are all methyl or ethyl.
  • the group "A" is a divalent radical selected from C,-C 10 alkylene, C 2 -C 10 alkenylene, 0,-0, 0 alkynylene, C,-C,o hydroxyalkylene, symmetric or asymmetric di-C,-C 10 -alkylenether, arylene, arylene-C,-C,o-alkylene, or 0,-0, 0 - alkylenearyl-C,-C,o alkylene.
  • A is a divalent C,-C 5 alkylene, C 2 - C 5 alkenylene, C 2 -C 5 hydroxyalkylene, or symmetric di-C 2 -C 5 -alkylenether, and most preferably "A" is -CH 2 CH 2 CH 2 -, -CH 2 CH(OH)CH 2 - or -CH 2 CH 2 OCH 2 CH 2 -.
  • the group “B” is a divalent radical selected from 0,-0, 0 alkylene, C 2 -C 10 alkenylene, C 2 -C 10 alkynylene, 0,-0, 0 hydroxyalkylene, arylene, arylene-C,- 0, 0 -alkylene, or Ci-C ⁇ -alkylenearyl-C ⁇ Cio-alkylene.
  • "B” is C,-C 5 ; alkylene, C 2 -C 5 alkenylene, C 2 -C 5 hydroxyalkylene, arylene, arylene-C,-C 5 - alkyiene, or C ⁇ Cs-alkylenearyl-C ⁇ Cs-alkylene.
  • B is a divalent radical selected from 0,-0, 0 alkylene, C 2 -C 10 alkenylene, C 2 -C 10 alkynylene, 0,-0, 0 hydroxyalkylene, arylene, arylene-C,- 0, 0 -alky
  • the counter ion, X 2* is a divalent counter ion, two monovalent counter ions, or a fraction of a polyvalent counter ion sufficient to balance the cationic charge in the repeating unit which forms the ionene polymer backbone.
  • X 2' is two monovalent anions selected from a halide anion and a trihalide anion and more preferably, chloride or bromide, lonene polymers having trihalide counter ions are described in U.S. Patent No. 3,778,476, the disclosure of which is incorporated here by reference.
  • the ionene polymers having the repeating unit of formula I may be prepared by a number of known methods. One method is to react a diamine of the formula R 1 R 2 N-B-NR 1 R 2 with a dihalide of the formula X-A-X. lonene polymers having this repeating unit and methods for their preparation are described, for example, in U.S. Patents Nos. 3,874,870; 3,931,319; 4,025,627; 4,027,020; 4,506,081; and 5,093,078, the disclosure of each of which is inco ⁇ orated here by reference. The biological activity of ionene polymers having the repeating unit of formula I is also described in these patents.
  • a particularly preferred ionene polymer is poly[oxyethylene- (dimethyliminio)ethylene(dimethyliminio)ethylene] dichloride.
  • R 1 , R 2 , R 3 and R 4 are each methyl, A is
  • BUSAN® 77 and WSCP® are biocides used primarily in aqueous systems, including metalworking fluids, for tnicroorganism control.
  • ionene polymer having a repeating unit of formula I is the ionene polymer where R 1 , R 2 , R 3 and R 4 are each methyl, A is -CH 2 CH(OH)CH 2 -, B is -CH 2 CH 2 -and X 2 " is 2 Of.
  • This ionene polymer is a reaction product of N.N.N'.N'-tetramethyl-l ⁇ -ethanediamine with
  • (chloromethyl)oxirane has an average molecular weight of 1 ,000-5,000.
  • the polymer is available from Buckman Laboratories, Inc. as BUSAN® 79 product and WSCP® 11 product, which are each 60% aqueous solutions of the polymer.
  • a second type of ionene polymer comprises the repeating unit of
  • X ' is a monovalent counter ion, one half of a divalent counter ion, or a fraction of a polyvalent counter ion sufficient to balance the cationic charge of the repeating unit which forms the ionene polymer.
  • X ' may be, for example, a halide or trihalide anion, and X * is preferably chloride or bromide.
  • the ionene polymers having the repeating unit of formula II may be prepared by known methods. One method is to react an amine of the formula R 1 R 2 NH with a haloepoxide such as epichlorohydrin. lonene polymers having the repeating unit of formula II are described, for example, in U.S. Patents Nos. 4,111 ,679 and 5,051,124, the disclosure of each of which is incorporated here by reference. The biological activity of ionene polymers having the repeating unit of formula II is also described in these patents. Preferred ionene polymers having the repeating unit of formula II are those where R 1 and R 2 are each methyl, A is -CH 2 CH(OH)CH 2 -, and X- is Cl " .
  • This polymer is obtained as a reaction product of N-dimethylamine with (chloromethyl)oxirane, and has an average molecular weight of 2,000-10,000.
  • the polymer is available from Buckman Laboratories, Inc. as the BUSAN® 1055 product, a 50% aqueous dispersion of the polymer.
  • ionene polymer having the repeating unit of formula II is obtained as a reaction product of dimethylamine with elchlorohydrin, where R 1 and R 2 are each methyl, A is and -CH 2 CH(OH)CH 2 - and X " is Cl".
  • This ionene polymer has a 5,000-10,000 average molecular weight, and is available from Buckman Laboratories, Inc. in a 50% aqueous solution as the BUSAN® 1055 product.
  • a third type of ionene polymer comprises a repeating unit of formula III:
  • the group B' is ⁇ - [CH 2 -CH(OH)-CH 2 -N + R' 2 -(CHR , ) n -NH-C(0)-NH]-, X " ⁇ or ⁇ -[(CHR') n -N * R 2 - CH 2 -CH(OH)-CH 2 ]-, X ⁇ .
  • the variables n and p independently vary from 2 to 12.
  • Each R' is independently hydrogen or a lower alkyl group.
  • X 2" is a divalent counter ion, two monovalent counter ions, or a fraction of a polyvalent counter Ion sufficient to balance the cationic charge in the group R.
  • X is a monovalent counter ion, one half of a divalent counter ion or a fraction of a polyvalent counter ion sufficient to balance the cationic charge in the group B'.
  • R' is hydrogen or C,-C 4 alkyl, n is 2-6, and p is 2-6. Most preferably, R' is hydrogen or methyl, n is 3 and p is 2.
  • Preferred counter ions for X 2' and X are the same as those discussed above for formulae I and ll.
  • the polymers of formula III are derived by known methods from bis-(dialkylaminoalkyl) ureas, which are also known as urea diamines. lonene polymers of the formula III, methods of their preparation, and their biological activities are described in U.S. Patent No. 4,506,081 , the disclosure of which is incorporated here by reference.
  • Preferred ionene polymers having the repeating unit of formula III are those where R is urea diamine and B' is CH 2 CH(OH)CH 2 , and X ' is Cl " .
  • Available from Buckman Laboratories, Inc., ASTAT product and BL® 1090 product are 50% aqueous dispersions of this ionene polymer.
  • the ionene polymer is obtained as a reaction product of N,N'-bis-[1-(3-(dimethylamino)- propyl)] urea and epichlorohydrin, such ionene polymer having an average
  • lonene polymers comprising the repeating units of formulae I, ll, and III may also be cross-linked with primary, secondary or other polyfunctional amines using means known in the art. lonene polymers can be cross-linked either through the quaternary nitrogen atom or through another functional group attached to the polymer backbone or to a side chain.
  • the cross-linking co- reactants listed are ammonia, primary amines, alkylenediamines, polyglycolamines, piperazines, heteroaromatic diamines and aromatic diamines.
  • Patent No. 5,051,124 also describes methods of inhibiting the growth of
  • a preferred cross-linked ionene polymer has a repeating unit of formula
  • This ionene polymer is obtained as a reaction product of dimethylamine with epichlorohydrin, cross-linked with ethylenediamine, where R 1 and R 2 are each methyl, A is -CH 2 CH(OH)CH 2 - and X * is Cl " .
  • the ionene polymer has a
  • Another preferred cross-linked ionene polymer has a repeating unit of
  • the ionene polymer is cross-linked with ammonia. This ionene polymer
  • Buckman Laboratories, Inc. products BUSAN® 1099 or BUBOND® 65 are 25% aqueous dispersions of a cross-linked ionene polymer having
  • R 1 and R 2 are each methyl, A is -CH 2 CH(OH)CH 2 -, X " is Cl " , and the cross-linking agent is monomethylamine.
  • This preferred ionene polymer has a molecular weight of approximately 10,000-100,000.
  • the ionene polymers comprising the repeating units of formulae I, II, or
  • ionene III may also be capped, i.e., have a specific end group.
  • Capping may be achieved by means known in the art. For example, an excess of either reactant used to make the ionene polymer can be employed to provide a capping group. Altematively, a calculated quantity of a monofunctional tertiary amine or monofunctional substituted or unsubstituted alkyl halide can be reacted with an ionene polymer to obtain a capped ionene polymer, lonene polymers can be capped at one or both ends. Capped ionene polymers and their microbicidal properties are described in U.S. Patents Nos. 3,931,319 and 5,093,073, the disclosure of each of which is incorporated here by reference.
  • the salts of dodecylamine employed in the present invention preferably have the following general formula:
  • X is an anion or a fraction of a polyvalent counter ion sufficient to balance the cationic charge in the dodecylamine.
  • X is preferably the conjugate base of an organic or inorganic acid, i.e., X is derived from an organic or inorganic acid by loss of an ionizable proton.
  • suitable organic acids are the mono- and di-carboxylic acids; suitable inorganic acids include the hydrohalide acids, such as hydrochloric acid.
  • X is derived from an acyclic, cyclic, or aromatic mono- or
  • the carboxylic acid preferably has up to ten carbon atoms. If cyclic or aromatic, the ring may contain one or more heteroatoms, such as N, 0, or S.
  • the carboxylic acid may also be substituted by any suitable substituent that does not adversely effect the activity of the inventive compositions.
  • suitable substituents include alkyl groups, substituted alkyl groups, alkenyl groups, substituted alkenyl groups, amino groups, oxo groups, halogen atoms, etc.
  • carboxylic acid groups include: acetyl, propionyl, butyryl, citral, lactyl, valeryl, phthalyl, succinyl, octanoyl, nonanoyl, formyl, sorbyl, oxalyl, lauryl, and benzoyl.
  • organic acid groups may also be used in the present invention.
  • the dodecyl group of the dodecylamine may be branched or unbranched, i.e., straight chain. Preferably, the dodecyl group is unbranched.
  • the dodecyl group may be unsubstituted or substituted by one or more substituents that do not adversely effect the activity of the inventive salts.
  • suitable substituents include alkyl groups, alkenyl groups, alkoxy groups, aryl groups, aralkyl groups, hydroxy groups, oxo groups (to form a ketone), acid groups and derivatives thereof, such as esters and amides, and halogen atoms.
  • the dodecyl group is unsubstituted.
  • One or more of the hydrogen atoms bound to the nitrogen atom may be replaced by a suitable substituent to give a secondary, tertiary, or quaternary
  • amine salt of dodecylamine Preferably, a primary amine salt of dodecylamine
  • carboxylic acid salts of dodecylamine are particulariy preferred in the practice of the present invention: dodecylamine acetate, dodecylamine propionate, dodecylamine butyrate, dodecylamine citrate, dodecylamine lactate, dodecylamine valerate, dodecylamine phthalate, dodecylamine succinate, dodecylamine octanoate, dodecylamine nonanate, dodecylamine formate, dodecylamine sorbate, dodecylamine oxalate, dodecylamine iaurate, dodecylamine benzoate, dodecylamine 2- hydroxybenzoate, dodecylamine 3-hydroxybenzoate, or dodecylamine 4- hydroxybenzoate.
  • dodecylamine acetate dodecylamine propionate, dodecylamine butyrate, dodecylamine valerate, dodecylamine phthalate, dodecylamine succinate, dodecylamine citrate, and dodecylamine lactate.
  • dodecylamine acetate dodecylamine propionate
  • dodecylamine butyrate dodecylamine valerate
  • dodecylamine phthalate dodecylamine succinate
  • dodecylamine citrate dodecylamine lactate.
  • dodecylamine lactate dodecylamine lactate
  • the salts of dodecylamine are preferably prepared by reacting
  • Suitable acids groups are available in their acid or salt form either commercially from laboratory supply houses or can be prepared from readily
  • the synthesis of the amine salts generally can be carried out in a solvent which may be a solvent for at least one of the reactants but which is generally a solvent for the desired product.
  • Preferred solvent systems include inorganic acids and organic acids or alcohols. Most preferred is acetic acid.
  • the temperature of reaction may be readily determined by one skilled in the art depending on the particular reactants employed. Preferably the temperature of reaction varies from 40°C to 110 ⁇ C or more, more preferably the temperature of the reaction is between 70°C and 100°C.
  • the reaction is
  • reaction is complete when the pH meter indicates that the limiting reactant has been neutralized.
  • reaction is stirred for 30 min to 2 hours, preferably for about 1 to 2 hours.
  • the reaction product can be worked up using well-known techniques to isolate and purify the desired salt of dodecylamine. Excess reactants and any solids formed during the reaction can be filtered off, and the filtrate evaporated to yield the crude product. In cases where the desired salt compound is a solid, the product of the reaction can be recrystallized from an appropriate solvent to yield a more pure compound. It should be noted, however, that both pure and crude salts of dodecylamine can be used for in the compositions and methods of this in ⁇ vention.
  • the preparation of the salts is not limited to the exact process or steps described above. Any of procedures known to the art which yield the desired end product may be used.
  • the particular salt of dodecylamine employed may be selected based on the compatibility of these compounds with the materials or media. Compatibility is determined by criteria such as solubility in the fluid system and lack of reactivity with the fluid or material or media in question. The compatibility is readily determined by one ordinary skill by adding the salt of dodecylamine to the material or media to be used. When used in a fluid system it is preferable that the salt of dodecylamine be freely soluble in the particular fluid resulting in a uniform solution or dispersion.
  • components (a) and (b) are used in synergistically effective amounts.
  • the weight ratios of (a) to (b) vary depending on the type of microorganisms and material or media to which the composition is applied. One skilled in the art can readily determine without undue experimentation, the appropriate weight ratios for a specific application.
  • the ratio of component (a) to component (b) preferably ranges from 1:99 to 99:1, more preferably from 1 :30 to 30: 1 , and most preferably 1 :2 to 2: 1.
  • the composition may be prepared in liquid form by dissolving the composition in water or in an organic solvent, or in dry form by adsorbing onto a suitable vehicle or it can be compounded into a tablet form.
  • the preservative may be prepared in an emulsion form by emulsifying it in water, or if necessary, by adding a surfactant. Additional chemicals, such as insecticides, may be added to the foregoing preparations depending upon the intended use of the preparation.
  • composition could vary depending upon the intended use.
  • the composition could vary depending upon the intended use.
  • composition could be applied by spraying or brushing onto the material or product.
  • the material or product in question could also be treated by dipping in a suitable formulation of the composition.
  • the composition In a liquid or liquid-like medium, the composition could be added into the medium by pouring, or by metering with a suitable device so that a solution or a dispersion of the composition could be produced.
  • Qa Concentration of compound A in parts per million, acting alone, which produced an end point.
  • Qb Concentration of compound B in parts per million, acting alone, which produced an end point.
  • QA Concentration of compound A in parts per million, in the mixture, which produced an end point.
  • QB Concentration of compound B in parts per million, in the mixture, which produced an end point.
  • Table 1 Synergistic and additive effect of polyquat combinations with dodeclyamine acetate versus selected algae species.
  • an effective fungicidal, bactericidal or algicidal response can be obtained when the synergistic combination is employed in concentrations ranging preferably from about 0.01 ppm to about 1% (i.e., about 10,000 ppm) of the ionene polymer, more preferably about 0.1 to about 5000 ppm, and most preferably about 0.1 ppm to about 1000 ppm, and preferably from about 0.01 to about 5000p pm of the salt of dodecylamine, more preferably about 0.1 to about 2000 ppm, and most preferably about 0.1 to about 1000 ppm.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
PCT/US1997/001967 1996-02-07 1997-02-06 Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same WO1997028687A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AU21187/97A AU724312B2 (en) 1996-02-07 1997-02-06 Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same
NZ331248A NZ331248A (en) 1996-02-07 1997-02-06 Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same
AT97906516T ATE209438T1 (de) 1996-02-07 1997-02-06 Synergistische antimikrobielle zusammensetzungen, die ein ionene-polymer und ein dodecylaminsalz enthalten und verfahren zu ihrer verwendung
JP52868297A JP3939355B2 (ja) 1996-02-07 1997-02-06 イオネンポリマーおよびドデシルアミン塩を含有する相乗的殺菌剤組成物ならびにその使用方法
BR9707318A BR9707318A (pt) 1996-02-07 1997-02-06 Composição microbicida e método para controlar o crescimento de pelos menos um microorganismo
SK1019-98A SK101998A3 (en) 1996-02-07 1997-02-06 Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same
CA002247375A CA2247375C (en) 1996-02-07 1997-02-06 Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same
DE69708610T DE69708610T2 (de) 1996-02-07 1997-02-06 Synergistische antimikrobielle zusammensetzungen, die ein ionene-polymer und ein dodecylaminsalz enthalten und verfahren zu ihrer verwendung
EP97906516A EP0884944B1 (en) 1996-02-07 1997-02-06 Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same
NO983610A NO983610L (no) 1996-02-07 1998-08-06 Synergistiske anti-mikrobielle blandinger inneholdende ionen polymer og et salt av dodecylamin, samt en fremgangsmÕte for Õ anvende nevnte blandinger

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1129096P 1996-02-07 1996-02-07
US60/011,290 1996-02-07

Publications (1)

Publication Number Publication Date
WO1997028687A1 true WO1997028687A1 (en) 1997-08-14

Family

ID=21749727

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/001967 WO1997028687A1 (en) 1996-02-07 1997-02-06 Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same

Country Status (17)

Country Link
US (2) US5843865A (zh)
EP (1) EP0884944B1 (zh)
JP (1) JP3939355B2 (zh)
CN (1) CN1105496C (zh)
AR (1) AR005764A1 (zh)
AT (1) ATE209438T1 (zh)
AU (1) AU724312B2 (zh)
BR (1) BR9707318A (zh)
CA (1) CA2247375C (zh)
CZ (1) CZ233698A3 (zh)
ES (1) ES2166066T3 (zh)
MX (1) MX9806356A (zh)
NO (1) NO983610L (zh)
NZ (1) NZ331248A (zh)
SK (1) SK101998A3 (zh)
WO (1) WO1997028687A1 (zh)
ZA (1) ZA971009B (zh)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013715A1 (en) * 1997-09-16 1999-03-25 Buckman Laboratories International, Inc. Synergistic antimicrobial compositions containing dodecylmorpholine or a salt thereof and dodecylamine or a salt thereof
WO2005014687A1 (de) * 2003-08-06 2005-02-17 Basf Aktiengesellschaft Epichlorhydrinamin-polymere zur oberflächenbehandlung von leder
WO2006026166A1 (en) * 2004-08-26 2006-03-09 Bausch & Lomb Incorporated Compositions containing trialkanolamine alkoxylate buffer
US8829055B2 (en) 2006-03-23 2014-09-09 Kao Corporation Biofilm formation inhibitor composition
WO2019244464A1 (ja) * 2018-06-22 2019-12-26 パナソニック株式会社 有機塩とこれを備えるヒドロキシラジカルセンサ及び検出メディア

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6667198A (en) * 1997-02-26 1998-09-18 Eli Lilly And Company Process for preparing pharmaceutical compounds
AU4679900A (en) * 1999-04-30 2000-11-17 Slil Biomedical Corporation Conformationally restricted polyamine analogs as disease therapies
JP2002543163A (ja) 1999-04-30 2002-12-17 スリル バイオメディカル コーポレイション 癌および前立腺疾患のための治療としての結合体
WO2001012561A1 (en) * 1999-08-17 2001-02-22 Ipsilon Pools (Proprietary) Limited A biocidal composition and a method of treating water
US6419838B1 (en) 2000-01-19 2002-07-16 Albemarle Corporation Synergistic combinations of oxidizing agents and alkylamines for biofilm control and deactivation
US6379563B1 (en) 2000-01-19 2002-04-30 Albemarle Corporation Alkylamines as biofilm deactivation agents
US6514458B1 (en) * 2000-02-25 2003-02-04 Ge Betz, Inc. Method for removing microbes from surfaces
JP3784609B2 (ja) * 2000-03-31 2006-06-14 日華化学株式会社 繊維用抗菌剤及び抗菌性繊維製品
DE60118179D1 (de) * 2000-06-02 2006-05-11 Arch Chem Inc Behandlung von zirkulierenden wassersystemen
JP2004513136A (ja) 2000-11-08 2004-04-30 スリル バイオメディカル コーポレーション 抗癌剤として有用な新規ポリアミンアナログ−アミノ酸結合体
NZ526821A (en) * 2001-01-18 2005-02-25 Genzyme Corp Ionene polymers and their use as antimicrobial agents
JP3542940B2 (ja) * 2001-04-27 2004-07-14 日華化学株式会社 殺菌消毒剤、抗菌性薬剤及び抗菌性材料
EP1436246A1 (en) * 2001-10-16 2004-07-14 SLIL Biomedical Corporation Oligoamine compounds and derivatives thereof for cancer therapy
AU2003237529A1 (en) * 2002-01-22 2003-09-02 Lonza Ag Antimicrobial composition including a triamine and a biocide
AU2003291087A1 (en) * 2002-11-19 2004-06-15 Genzyme Corporation Ionene oligomers and polymers
US20040175352A1 (en) * 2003-03-06 2004-09-09 David Oppong Microbicidal compositions including an ionene polymer and 2,4,4-trichloro-2-hydroxydiphenyl ether, and methods of using the same
US8431114B2 (en) * 2004-10-07 2013-04-30 Actamax Surgical Materials, Llc Polysaccharide-based polymer tissue adhesive for medical use
JP2008100964A (ja) * 2006-10-20 2008-05-01 Kao Corp バイオフィルム生成抑制剤組成物
US8282959B2 (en) * 2006-11-27 2012-10-09 Actamax Surgical Materials, Llc Branched end reactants and polymeric hydrogel tissue adhesives therefrom
US20090035249A1 (en) * 2007-08-02 2009-02-05 Bhatia Sujata K Method of inhibiting proliferation of Escherichia coli
US8426492B2 (en) * 2007-11-14 2013-04-23 Actamax Surgical Materials, Llc Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use
US8551136B2 (en) 2008-07-17 2013-10-08 Actamax Surgical Materials, Llc High swell, long-lived hydrogel sealant
US8466327B2 (en) 2008-11-19 2013-06-18 Actamax Surgical Materials, Llc Aldehyde-functionalized polyethers and method of making same
US9044529B2 (en) * 2008-11-19 2015-06-02 Actamax Surgical Materials, Llc Hydrogel tissue adhesive formed from aminated polysaccharide and aldehyde-functionalized multi-arm polyether
US8951989B2 (en) 2009-04-09 2015-02-10 Actamax Surgical Materials, Llc Hydrogel tissue adhesive having reduced degradation time
US8796242B2 (en) 2009-07-02 2014-08-05 Actamax Surgical Materials, Llc Hydrogel tissue adhesive for medical use
WO2011002956A1 (en) 2009-07-02 2011-01-06 E. I. Du Pont De Nemours And Company Aldehyde-functionalized polysaccharides
EP2448604B1 (en) 2009-07-02 2016-03-23 Actamax Surgical Materials LLC Hydrogel tissue adhesive for medical use
US8580950B2 (en) 2009-07-02 2013-11-12 Actamax Surgical Materials, Llc Aldehyde-functionalized polysaccharides
US8859705B2 (en) 2012-11-19 2014-10-14 Actamax Surgical Materials Llc Hydrogel tissue adhesive having decreased gelation time and decreased degradation time
WO2015017340A2 (en) 2013-07-29 2015-02-05 Actamax Surgical Materials, Llc Low swell tissue adhesive and sealant formulations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3140976A (en) * 1960-12-16 1964-07-14 Armour Pharma Quaternary ammonium germicide
WO1995012976A1 (en) * 1993-11-12 1995-05-18 Bruce Green Disinfectant composition

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3003915A (en) * 1961-10-10 Method of destroying lactobacilli em-
US28808A (en) * 1860-06-19 Warped surfaces
US3778476A (en) * 1970-05-11 1973-12-11 California Inst Of Techn Polymeric organic halogen salts
USRE28808E (en) * 1972-02-04 1976-05-11 American Cyanamid Company Polyquaternary flocculants
US3738945A (en) * 1972-02-04 1973-06-12 H Panzer Polyquaternary flocculants
US3894947A (en) * 1973-04-02 1975-07-15 American Cyanamid Co Process for treating industrial wastes
US3894946A (en) * 1973-04-02 1975-07-15 American Cyanamid Co Process for treating industrial wastes
US3874870A (en) * 1973-12-18 1975-04-01 Mill Master Onyx Corp Microbiocidal polymeric quarternary ammonium compounds
US4025627A (en) * 1973-12-18 1977-05-24 Millmaster Onyx Corporation Microbiocidal polymeric quaternary ammonium compounds
US3931319A (en) * 1974-10-29 1976-01-06 Millmaster Onyx Corporation Capped polymers
US4027020A (en) * 1974-10-29 1977-05-31 Millmaster Onyx Corporation Randomly terminated capped polymers
US4089977A (en) * 1976-11-24 1978-05-16 Kewanee Industries Polymeric anti-microbial agent
US4147627A (en) * 1977-02-07 1979-04-03 American Cyanamid Company Process for scale control using mixtures of polycationic and polyanionic polymers
US4164521A (en) * 1977-02-07 1979-08-14 American Cyanamid Company Mixtures of polycationic and polyanionic polymers for scale control
US4111679A (en) * 1977-08-17 1978-09-05 Chemed Corporation Polyquaternary compounds for the control of microbiological growth
US4166041A (en) * 1977-12-15 1979-08-28 American Cyanamid Company Process for magnesium scale control using mixtures of polycationic and polyanionic polymers
US4104161A (en) * 1978-04-18 1978-08-01 Nalco Chemical Company Method for treating aqueous wastes containing at least 1% proteinaceous matter
US4778813A (en) * 1981-07-07 1988-10-18 Buckman Laboratories International, Inc. Polymeric quaternary ammonium compounds, their preparation and use
US4506081A (en) * 1982-09-02 1985-03-19 Buckman Laboratories, Inc. Polymeric quaternary ammonium compounds and their uses
US4581058A (en) * 1982-09-02 1986-04-08 Buckman Laboratories, Inc. Polymeric quaternary ammonium compounds and their uses
US4606773A (en) * 1984-12-10 1986-08-19 Nalco Chemical Company Emulsification of alkenyl succinic anhydride sizing agents
US4970211A (en) * 1985-05-20 1990-11-13 Buckman Laboratories International, Inc. Ionene polymeric compositions, their preparation and use
US4769155A (en) * 1987-08-19 1988-09-06 Nalco Chemical Company Turbidity reduction
CH673545A5 (zh) * 1987-10-02 1990-03-15 Industrieorientierte Forsch
DE3840103C2 (de) * 1988-11-28 1994-10-06 Bayrol Chem Fab Gmbh Verfahren zum Entkeimen und Entalgung von Wasser
US4960590A (en) * 1989-02-10 1990-10-02 Buckman Laboratories International, Inc. Novel polymeric quaternary ammonium trihalides
US5128100A (en) * 1989-10-12 1992-07-07 Buckman Laboratories, Intl., Inc. Process for inhibiting bacterial adhesion and controlling biological fouling in aqueous systems
US5051124A (en) * 1989-10-24 1991-09-24 Buckman Laboratories International, Inc. Microbicidal compositions of dimethylamine-epichlorohydrin amines

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3140976A (en) * 1960-12-16 1964-07-14 Armour Pharma Quaternary ammonium germicide
WO1995012976A1 (en) * 1993-11-12 1995-05-18 Bruce Green Disinfectant composition

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013715A1 (en) * 1997-09-16 1999-03-25 Buckman Laboratories International, Inc. Synergistic antimicrobial compositions containing dodecylmorpholine or a salt thereof and dodecylamine or a salt thereof
US5929073A (en) * 1997-09-16 1999-07-27 Buckman Laboratories International, Inc. Synergistic antimicrobial compositions containing dodecylmorpholine a salt thereof and dodecylamine or a salt thereof
AU745268B2 (en) * 1997-09-16 2002-03-14 Buckman Laboratories International, Inc. Synergistic antimicrobial compositions containing dodecylmorpholine or a salt thereof and dodecylamine or salt thereof
WO2005014687A1 (de) * 2003-08-06 2005-02-17 Basf Aktiengesellschaft Epichlorhydrinamin-polymere zur oberflächenbehandlung von leder
US7728072B2 (en) 2003-08-06 2010-06-01 Basf Aktiengesellschaft Epichlorohydrin amine polymers used for treating the surface of leather
WO2006026166A1 (en) * 2004-08-26 2006-03-09 Bausch & Lomb Incorporated Compositions containing trialkanolamine alkoxylate buffer
US7629386B2 (en) 2004-08-26 2009-12-08 Bausch + Lomb Incorporated Compositions containing trialkanolamine alkoxylate buffer
US8829055B2 (en) 2006-03-23 2014-09-09 Kao Corporation Biofilm formation inhibitor composition
WO2019244464A1 (ja) * 2018-06-22 2019-12-26 パナソニック株式会社 有機塩とこれを備えるヒドロキシラジカルセンサ及び検出メディア
JPWO2019244464A1 (ja) * 2018-06-22 2021-07-26 パナソニック株式会社 有機塩とこれを備えるヒドロキシラジカルセンサ及び検出メディア
US12078644B2 (en) 2018-06-22 2024-09-03 Panasonic Holdings Corporation Organic salt, hydroxy-radical sensor including same, and detection medium

Also Published As

Publication number Publication date
JP3939355B2 (ja) 2007-07-04
BR9707318A (pt) 1999-04-13
US5843865A (en) 1998-12-01
NO983610D0 (no) 1998-08-06
CA2247375A1 (en) 1997-08-14
EP0884944A1 (en) 1998-12-23
ES2166066T3 (es) 2002-04-01
NZ331248A (en) 2000-03-27
SK101998A3 (en) 1998-12-02
AU724312B2 (en) 2000-09-14
CN1210442A (zh) 1999-03-10
CZ233698A3 (cs) 1998-12-16
CA2247375C (en) 2004-03-30
EP0884944B1 (en) 2001-11-28
JP2000504690A (ja) 2000-04-18
MX9806356A (es) 1998-10-31
AR005764A1 (es) 1999-07-14
AU2118797A (en) 1997-08-28
ZA971009B (en) 1997-10-30
ATE209438T1 (de) 2001-12-15
US6103666A (en) 2000-08-15
CN1105496C (zh) 2003-04-16
NO983610L (no) 1998-10-07

Similar Documents

Publication Publication Date Title
EP0884944B1 (en) Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same
US5776960A (en) Synergistic antimicrobial compositions containing an ionene polymer and a pyrithione salt and methods of using the same
US5866016A (en) Methods and compositions for controlling biofouling using combinations of an ionene polymer and a salt of dodecylamine
WO1995020319A1 (en) Synergistic antimicrobial compositions containing a halogenated acetophenone and an organic acid
ZA200506601B (en) Microbicidal compositions including an ionene polymer and 2,4,4'-trichloro-2'-hydroxydiphenyl ether and methods of using the same
WO1995020321A1 (en) Synergistic antimicrobial compositions containing methylene-bis(thiocyanate) and an organic acid
NZ238927A (en) Biocidal compositions comprising a heterocycle and either an agent effecting membrane permeability, an isothiazolinone, an isothiazolothione or an aldehyde
JP2000502705A (ja) 1―ヒドロキシメチルピラゾールと保存薬とを含む相乗効果のある抗菌組成物
CA2259384C (en) Methods and compositions for controlling biofouling using combinations of an ionene polymer and a salt of dodecylamine
JP4347421B2 (ja) プロピコナゾールとドデシルアミンまたはドデシルアミン塩との組合せ殺微生物剤
DE69708610T2 (de) Synergistische antimikrobielle zusammensetzungen, die ein ionene-polymer und ein dodecylaminsalz enthalten und verfahren zu ihrer verwendung
JP4387587B2 (ja) ドデシルモルホリンまたはその塩およびドデシルアミンまたはその塩を含有する相乗的抗微生物組成物
AU9750201A (en) Synergistic antimicrobial compositions containing an ionene polymer and a pyrithione salt and methods of using the same
AU766899B2 (en) Synergistic antimicrobial compositions containing methylene-bis(thiocyanate) and an organic acid
CA2069453A1 (en) Biocide composition

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 97192098.2

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: PV1998-2336

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 101998

Country of ref document: SK

ENP Entry into the national phase

Ref document number: 2247375

Country of ref document: CA

Ref document number: 2247375

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 331248

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: PA/A/1998/006356

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1997906516

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: PV1998-2336

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1997906516

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: PV1998-2336

Country of ref document: CZ

WWG Wipo information: grant in national office

Ref document number: 1997906516

Country of ref document: EP